After a prolonged period of limited availability, the FDA has officially declared that Wegovy and Ozempic are once again fully accessible, effective February 21, 2025. This announcement marks a significant relief for many patients relying on these GLP-1 medications to manage weight and improve blood sugar control. Below, we outline the key points surrounding the […]